FDA Inspection 1061266 — Kaiser Permanente-Sunnyside Medical Center

Kaiser Permanente-Sunnyside Medical Center — FEI 3076999

The FDA completed an inspection of Kaiser Permanente-Sunnyside Medical Center on July 31, 2018 in Clackamas, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 31, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Clackamas, OR (United States)